Establishing a clinical ethics support service: lessons from the first 18 months of a new Australian service - a case study.

CECs Clinical ethics Clinical ethics committees Qualitative approach

Journal

BMC medical ethics
ISSN: 1472-6939
Titre abrégé: BMC Med Ethics
Pays: England
ID NLM: 101088680

Informations de publication

Date de publication:
11 08 2023
Historique:
received: 14 02 2023
accepted: 27 07 2023
medline: 14 8 2023
pubmed: 12 8 2023
entrez: 11 8 2023
Statut: epublish

Résumé

Although the importance of clinical ethics in contemporary clinical environments is established, development of formal clinical ethics services in the Australia health system has, to date, been ad hoc. This study was designed to systematically follow and reflect upon the first 18 months of activity by a newly established service, to examine key barriers and facilitators to establishing a new service in an Australian hospital setting. HOW THE STUDY WAS PERFORMED AND STATISTICAL TESTS USED: A qualitative case study approach was utilised. The study gathered and analysed data using observations of service committee meetings, document analysis of agendas and minutes, and semi-structured interviews with committee members to generate semantic themes. By interpreting the thematic findings in reference to national capacity building resources, this study also aimed to provide practice-based reflections for other health agencies. THE MAIN FINDINGS: An overarching theme identified in the data was a strong commitment to supporting clinicians facing difficult patient care decisions and navigating difficult discussions with patients and families. Another key theme was the role of the new clinical ethics support service in providing clinicians with a pathway to raise system-wide issues with the organisation Executive. While there was strong clinical engagement, consumer and community participation remained a challenge, as did unresolved governance issues and a need for clearer policy relationship between the service and the organisation. Considering these themes in relation to the national capacity building resources, the study identifies three areas likely to require ongoing development and negotiation. These are: the role of the clinical ethics support service as a link between the workforce and the Executive; the incorporation of consumers and patients; and ethical reasoning. To improve the effectiveness of the service, it is necessary to increase clarity on the service's role at the governance and policy level, as well as develop strategies for engaging consumers, patients and families. Finally, the capacity of the service to reflect on complex cases may be enhanced through explicit discussions of various different ethical frameworks and ways of deliberating.

Sections du résumé

BACKGROUND
Although the importance of clinical ethics in contemporary clinical environments is established, development of formal clinical ethics services in the Australia health system has, to date, been ad hoc. This study was designed to systematically follow and reflect upon the first 18 months of activity by a newly established service, to examine key barriers and facilitators to establishing a new service in an Australian hospital setting.
METHODS
HOW THE STUDY WAS PERFORMED AND STATISTICAL TESTS USED: A qualitative case study approach was utilised. The study gathered and analysed data using observations of service committee meetings, document analysis of agendas and minutes, and semi-structured interviews with committee members to generate semantic themes. By interpreting the thematic findings in reference to national capacity building resources, this study also aimed to provide practice-based reflections for other health agencies.
RESULTS
THE MAIN FINDINGS: An overarching theme identified in the data was a strong commitment to supporting clinicians facing difficult patient care decisions and navigating difficult discussions with patients and families. Another key theme was the role of the new clinical ethics support service in providing clinicians with a pathway to raise system-wide issues with the organisation Executive. While there was strong clinical engagement, consumer and community participation remained a challenge, as did unresolved governance issues and a need for clearer policy relationship between the service and the organisation. Considering these themes in relation to the national capacity building resources, the study identifies three areas likely to require ongoing development and negotiation. These are: the role of the clinical ethics support service as a link between the workforce and the Executive; the incorporation of consumers and patients; and ethical reasoning. To improve the effectiveness of the service, it is necessary to increase clarity on the service's role at the governance and policy level, as well as develop strategies for engaging consumers, patients and families. Finally, the capacity of the service to reflect on complex cases may be enhanced through explicit discussions of various different ethical frameworks and ways of deliberating.

Identifiants

pubmed: 37568138
doi: 10.1186/s12910-023-00942-9
pii: 10.1186/s12910-023-00942-9
pmc: PMC10422737
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

62

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

J Med Ethics. 2020 Feb;46(2):66-70
pubmed: 31488518
Camb Q Healthc Ethics. 2006 Winter;15(1):101-6
pubmed: 16529312
J Med Ethics. 2012 Apr;38(4):210-4
pubmed: 22167385
J Med Ethics. 2022 Apr;48(4):244-249
pubmed: 33811113
BMC Med Ethics. 2021 Jul 29;22(1):107
pubmed: 34325688
BMC Med Res Methodol. 2011 Jun 27;11:100
pubmed: 21707982

Auteurs

Elizabeth Hoon (E)

School of Public Health, The University of Adelaide, PO Box 5005, Adelaide, SA, 5005, Australia. Elizabeth.Hoon@adelaide.edu.au.
Adelaide Medical School, The University of Adelaide, PO Box 5005, Adelaide, SA, 5005, Australia. Elizabeth.Hoon@adelaide.edu.au.

Jessie Edwards (J)

Adelaide Medical School, The University of Adelaide, PO Box 5005, Adelaide, SA, 5005, Australia.

Gill Harvey (G)

College of Nursing and Health Sciences, Flinders University, PO Box 2100, Adelaide, SA, 5001, Australia.

Jaklin Eliott (J)

School of Public Health, The University of Adelaide, PO Box 5005, Adelaide, SA, 5005, Australia.

Tracy Merlin (T)

School of Public Health, The University of Adelaide, PO Box 5005, Adelaide, SA, 5005, Australia.

Drew Carter (D)

School of Public Health, The University of Adelaide, PO Box 5005, Adelaide, SA, 5005, Australia.

Stewart Moodie (S)

Central Adelaide Local Health Network, Adelaide, SA, 5000, Australia.

Gerry O'Callaghan (G)

School of Public Health, The University of Adelaide, PO Box 5005, Adelaide, SA, 5005, Australia.
Central Adelaide Local Health Network, Adelaide, SA, 5000, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH